Comparison of oral versus intravenous etoposide in the management of small‐cell lung cancer; A real‐world, population‐based study
Abstract Background We looked at the utility of PO versus IV etoposide for first‐line treatment in combination with a platinum agent (cisplatin/carboplatin) for Small‐Cell Lung Cancer (SCLC). Methods Patients with SCLC in Alberta from 2008 to 2015 were identified through the registry. Patients were...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | The Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/crj.13266 |